Cetera Investment Advisers Adma Biologics, Inc. Transaction History
Cetera Investment Advisers
- $45.9 Billion
- Q4 2024
A detailed history of Cetera Investment Advisers transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 49,841 shares of ADMA stock, worth $986,851. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,841
Previous 55,927
10.88%
Holding current value
$986,851
Previous $1.12 Million
23.55%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$369 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$360 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$294 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$224 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$110 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.89B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...